Immunity Against Mycobacteria

Seminars in Respiratory and Critical Care Medicine

Volumn 25, Issue 1, 2004, Pages 53-61

  Mason, Carol M ^a   Ali, Juzar ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Granuloma; Immunity; Mycobacteria

Indexed keywords

CYTOKINE;

BACTERIAL GROWTH; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; EPIDEMIC; GRANULOMA; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNITY; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

EID: 1542273546     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-822305     Document Type: Review

References (66)

1. World Health Organization. Groups at risk: report on the tuberculosis epidemic. Geneva: WHO; 1996
2. Raviglione M, Snider D Jr, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995;273:220-226
3. Sahn S, Neff T. Miliary tuberculosis. Am J Med 1974;56:495-505
4. Barnes P, Bloch A, Davidson P, Snider D. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324:1644-1650
5. Cohn D, O'Brien R, Geiter L, et al. American Thoracic Society/Centers for Disease Control and Prevention: targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-S247
6. Reiling N, Holscher C, Fehrenbach A, et al. Cutting edge: toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance in airborne infection with Mycobacterium tuberculosis. J Immunol 2002;169:3480-3484
7. Schlesinger L. Role of mononuclear phagocytes in M. tuberculosis pathogenesis. J Investig Med 1996;44:312-323
8. Sturgill-Koszcki S, Schlesinger P, Chakraborty P, et al. Lack of acidification in mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 1994;263:678-681
9. 2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase. J Immunol 2003;170:2811-2815
10. Russell D. Mycobacterium tuberculosis: here today and here tomorrow. Nature Reviews 2001;2:1-9
11. Brown D, Miles B, Zwilling B. Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: establishment of latency and reactivation. Infect Immun 1995;63:2243-2247
12. Bellamy R, Ruwende C, Corrah T, McAdam K, Whittle H, Hill A. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998;338:640-644
13. Schaible U, Sturgill-Koszycki S, Schlesinger P, Russell D. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J Immunol 1998;160:1290-1296
14. Denis M. Interferon-gamma-treated macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol 1991;132:150-157
15. Flesch I, Kaufmann S. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun 1991;59:3213-3218
16. Wang J, Wakeham J, Harkness R, Xing Z. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest 1999;103:1023-1029
17. Park A, Hondowicz B, Kopf M, Scott P. The role of IL-12 in maintaining resistance to Leishmania major. J Immunol 2002;168:5771-5777
18. Fulton S, Johnsen J, Wolf S, Sieburth D, Boom W. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun 1996;64:2523-2531
19. Flesch I, Hess J, Huang S, et al. Early interleukin 12 production by macrophages in response to mycobacteial infection depends on interferon-γ and tumor necrosis factor-α. J Exp Med 1995;181:1615-1621
20. Flynn J, Goldstein M, Triebold K, Sypek J, Wolf S, Bloom B. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 1995;155:2515-2524
21. Cooper A, Magram J, Ferrante J, Orme I. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997;186:39-45
22. Cooper A, Kipnis A, Turner J, Magram J, Ferrante J, Orme I. Mice lacking bioactive IL-12 can generate protective antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol 2002;168:1322-1327
23. Yamada H, Mizumo S, Horai R, Iwakura Y, Sugawara I. Protective role of interleukin-1 in mycobacterial infection in IL-1 α/β double-knockout mice. Lab Invest 2000;80:759-767
24. Adams L, Mason C, Kolls J, Scollard D, Krahenbuhl J, Nelson S. Exacerbation of acute and chronic murine tuberculosis by administration of tumor necrosis factor receptor-expressing adenovirus. J Infect Dis 1995;171:400-405
25. Kindler V, Sappino A, Grau G, Piguet P, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 1989;56:731-740
26. Flynn J, Goldstein M, Chan J, et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995;2:561-572
27. Keane J, Gershon S, Wise R, et al. Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent. N Engl J Med 2001;345:1098-1104
28. Kremer L, Dupre L, Wolowczuk I, Locht C. In vivo immunomodulation following intradermal injection with DNA encoding IL-18. J Immunol 1999;163:3226-3231
29. Yamada G, Shijubo N, Shigehara K, Okamura H, Kurimoto M, Abe S. Increased levels of circulating interleukin-18 in patients with advanced tuberculosis. Am J Respir Crit Care Med 2000;161:1786-1789
30. Sugawara I, Yamada H, Kaneko H, Mizuno S, Takeda K, Akira S. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect Immun 1999;67:2585-2589
31. Orme I, Roberts A, Griffin J, Abrams J. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993;151:518-525
32. Gong J, Zhang M, Modlin R, et al. Interleukin-10 down-regulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 1996;64:913-918
33. Murray P, Wang L, Onufryk C, Tepper R, Young R. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997;158:315-321
34. Murray P, Young R. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 1999;67:3087-3095
35. Boussiotis V, Tsai E, Yunis E, et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000;105:1317-1325
36. Sugawara I, Yamada H, Mizuno S, Iwakura Y. IL-4 is required for defense against mycobacterial infection. Microbiol Immunol 2000;44:971-979
37. Adams L, Fukutomi Y, Krahenbuhl J. Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Infect Immun 1993;61:4173-4181
38. Luster A. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445
39. Sauty A, Dziejman M, Taha R, et al. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 1999;162:3549-3558
40. Sadek M, Sada E, Toossi Z, Schwander S, Rich E. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am J Respir Cell Mol Biol 1998;19:513-521
41. Saukkonen J, Bazydlo B, Thomas M, Streiter R, Keane J, Kornfeld H. β-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth. Infect Immun 2002;70:1684-1693
42. Qiu B, Frait K, Reich F, Komuniecki E, Chensue S. Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am J Pathol 2001;158:1503-1515
43. Rhoades E, Cooper A, Orme I. Chemokine response in mice infected with Mycobacterium tuberculosis. Infect Immun 1995;63:3871-3877
44. Lin Y, Zhang M, Barnes P. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect Immun 1998;66:1121-1126
45. Muller I, Cobbold S, Waldmann H, Kaufmann S. Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells. Infect Immun 1987;55:2037-2041
46. + T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon γ and nitric oxide synthase 2. J Exp Med 2000;192:347-358
47. Saunders B, Frank A, Orme I, Cooper A. CD4 is required for the development of a protective granulomatous response to pulmonary tuberculosis. Cell Immunol 2002;216:65-72
48. Graham N, Chaisson R. Tuberculosis and HIV infection: epidemiology, pathogenesis, and clinical aspects. Ann Allergy 1993;71:421-428
49. Cooper A, Dalton D, Stewart T, Griffin J, Russell D, Orme I. Disseminated tuberculosis in interferon γ gene-disrupted mice. J Exp Med 1993;178:2243-2247
50. Flynn J, Chan J, Triebold K, Dalton D, Stewart T, Bloom B. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-2254
51. Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 1996;335:1956-1961
52. Ottenhoff T, Kumararatne D, Casanova J. Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol Today 1998;19:491-494
53. Lopez-Maderuelo D, Arnalich F, Serantes R, et al. Interferon-γ and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003;167:970-975
54. Giosue S, Casarini M, Alemanno L, et al. Effects of aerosolized interferon-α in patients with pulmonary tuberculosis. Am J Respir Crit Care Med 1998;158:1156-1162
55. Condos R, Rom W, Schluger N. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ via aerosol. Lancet 1997;349:1513-1515
56. Zea A, Ochoa M, Ghosh P, et al. Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun 1998;66:499-504
57. Zea A, Culotta K, Ali J, et al. Alterations in T cell signal transduction proteins in patients with tuberculosis. FASEB J 2002;16:A300
58. + T cells primed for the production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect Immun 1999;67:3980-3988
59. Cooper A, D'Souza C, Frank A, Orme I. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms. Infect Immun 1997;65:1317-1320
60. + CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages. J Immunol 2000;165:353-363
61. Pinxteren LV, Cassidy J, Smedegaard B, Agger E, Andersen P. Control of latent Mycobacterium tuberculosis infection is dependent on CD8 T cells. Eur J Immunol 2000;30:3689-3698
62. Vordermeier H, Venkataprasad N, Harris D, Ivanyi J. Increase in tuberculous infection in the organs of B cell-deficient mice. Clin Exp Immunol 1996;106:312-316
63. Kaufmann S. γ/δ and other unconventional T lymphocytes: what do they see and what do they do? Proc Natl Acad Sci USA 1996;93:2272-2279
64. D'Souza C, Cooper A, Frank A, Mazzaccaro R, Bloom B, Orme I. An anti-inflammatory role for γδ T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol 1997;158:1217-1221
65. Gonzalez-Juarrero M, Turner O, Turner J, Marietta P, Brooks J, Orme I. Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis. Infect Immun 2001;69:1722-1728
66. Teitelbaum R, Glatman-Freedman A, Chen B, et al. A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. Proc Natl Acad Sci USA 1998;95:15688-15693